These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 31558699)

  • 1. SEPT9_i1 regulates human breast cancer cell motility through cytoskeletal and RhoA/FAK signaling pathway regulation.
    Zeng Y; Cao Y; Liu L; Zhao J; Zhang T; Xiao L; Jia M; Tian Q; Yu H; Chen S; Cai Y
    Cell Death Dis; 2019 Sep; 10(10):720. PubMed ID: 31558699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Septin 9_i2 is downregulated in tumors, impairs cancer cell migration and alters subnuclear actin filaments.
    Verdier-Pinard P; Salaun D; Bouguenina H; Shimada S; Pophillat M; Audebert S; Agavnian E; Coslet S; Charafe-Jauffret E; Tachibana T; Badache A
    Sci Rep; 2017 Mar; 7():44976. PubMed ID: 28338090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted knockdown of SEPT9_v1 inhibits tumor growth and angiogenesis of human prostate cancer cells concomitant with disruption of hypoxia-inducible factor-1 pathway.
    Amir S; Golan M; Mabjeesh NJ
    Mol Cancer Res; 2010 May; 8(5):643-52. PubMed ID: 20407014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The concerted action of SEPT9 and EPLIN modulates the adhesion and migration of human fibroblasts.
    Hecht M; Alber N; Marhoffer P; Johnsson N; Gronemeyer T
    Life Sci Alliance; 2024 Jul; 7(7):. PubMed ID: 38719752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Septin 9 isoforms promote tumorigenesis in mammary epithelial cells by increasing migration and ECM degradation through metalloproteinase secretion at focal adhesions.
    Marcus J; Bejerano-Sagie M; Patterson N; Bagchi S; Verkhusha VV; Connolly D; Goldberg GL; Golden A; Sharma VP; Condeelis J; Montagna C
    Oncogene; 2019 Jul; 38(30):5839-5859. PubMed ID: 31285548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardin-related transcription factor A (MRTF-A) activity-dependent cell adhesion is correlated to focal adhesion kinase (FAK) activity.
    Kishi T; Mayanagi T; Iwabuchi S; Akasaka T; Sobue K
    Oncotarget; 2016 Nov; 7(44):72113-72130. PubMed ID: 27708220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression.
    Connolly D; Yang Z; Castaldi M; Simmons N; Oktay MH; Coniglio S; Fazzari MJ; Verdier-Pinard P; Montagna C
    Breast Cancer Res; 2011 Aug; 13(4):R76. PubMed ID: 21831286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic profiling of the oncogenic septin 9 reveals isoform-specific interactions in breast cancer cells.
    Devlin L; Okletey J; Perkins G; Bowen JR; Nakos K; Montagna C; Spiliotis ET
    Proteomics; 2021 Oct; 21(19):e2100155. PubMed ID: 34409731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ARHGAP4-SEPT2-SEPT9 complex enables both up- and down-modulation of integrin-mediated focal adhesions, cell migration, and invasion.
    Kang N; Matsui TS; Liu S; Deguchi S
    Mol Biol Cell; 2021 Nov; 32(21):ar28. PubMed ID: 34524873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Septin11 promotes hepatocellular carcinoma cell motility by activating RhoA to regulate cytoskeleton and cell adhesion.
    Fu L; Wang X; Yang Y; Chen M; Kuerban A; Liu H; Dong Y; Cai Q; Ma M; Wu X
    Cell Death Dis; 2023 Apr; 14(4):280. PubMed ID: 37080972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AmotP130 regulates Rho GTPase and decreases breast cancer cell mobility.
    Chen ZL; Yang J; Shen YW; Li ST; Wang X; Lv M; Wang BY; Li P; Zhao W; Qiu RY; Liu Y; Liu PJ; Yang J
    J Cell Mol Med; 2018 Apr; 22(4):2390-2403. PubMed ID: 29377471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of caveolin-1 in low shear stress-induced breast cancer cell motility and adhesion: Roles of FAK/Src and ROCK/p-MLC pathways.
    Xiong N; Li S; Tang K; Bai H; Peng Y; Yang H; Wu C; Liu Y
    Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):12-22. PubMed ID: 27773611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forchlorfenuron disrupts SEPT9_i1 filaments and inhibits HIF-1.
    Vardi-Oknin D; Golan M; Mabjeesh NJ
    PLoS One; 2013; 8(8):e73179. PubMed ID: 23977378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enterolactone alters FAK-Src signaling and suppresses migration and invasion of lung cancer cell lines.
    Chikara S; Lindsey K; Borowicz P; Christofidou-Solomidou M; Reindl KM
    BMC Complement Altern Med; 2017 Jan; 17(1):30. PubMed ID: 28068967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Septin 9 isoform 1 (SEPT9_i1) specifically interacts with importin-α7 to drive hypoxia-inducible factor (HIF)-1α nuclear translocation.
    Tazat K; Schindler S; Depping R; Mabjeesh NJ
    Cytoskeleton (Hoboken); 2019 Jan; 76(1):123-130. PubMed ID: 29742803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxia-inducible factors mediate coordinated RhoA-ROCK1 expression and signaling in breast cancer cells.
    Gilkes DM; Xiang L; Lee SJ; Chaturvedi P; Hubbi ME; Wirtz D; Semenza GL
    Proc Natl Acad Sci U S A; 2014 Jan; 111(3):E384-93. PubMed ID: 24324133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SEPT9_i1 is required for the association between HIF-1α and importin-α to promote efficient nuclear translocation.
    Golan M; Mabjeesh NJ
    Cell Cycle; 2013 Jul; 12(14):2297-308. PubMed ID: 24067372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophosphatidic acid induces a migratory phenotype through a crosstalk between RhoA-Rock and Src-FAK signalling in colon cancer cells.
    Leve F; Marcondes TG; Bastos LG; Rabello SV; Tanaka MN; Morgado-Díaz JA
    Eur J Pharmacol; 2011 Dec; 671(1-3):7-17. PubMed ID: 21968138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paxillin, a novel controller in the signaling of estrogen to FAK/N-WASP/Arp2/3 complex in breast cancer cells.
    Shortrede JE; Uzair ID; Neira FJ; Flamini MI; Sanchez AM
    Mol Cell Endocrinol; 2016 Jul; 430():56-67. PubMed ID: 27095481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SEPT9_i1 and Septin Dynamics in Oncogenesis and Cancer Treatment.
    Jędrzejczak P; Saramowicz K; Kuś J; Barczuk J; Rozpędek-Kamińska W; Siwecka N; Galita G; Wiese W; Majsterek I
    Biomolecules; 2024 Sep; 14(9):. PubMed ID: 39334960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.